Literature DB >> 9303512

Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control study.

L Serfaty1, O Chazouillères, A Poujol-Robert, L Morand-Joubert, C Dubois, Y Chrétien, R E Poupon, J C Petit, R Poupon.   

Abstract

The role of the viral genotype, especially genotype 1b, in the severity of liver injury induced by chronic hepatitis C virus (HCV) infection is unclear, probably because of confounding factors such as the date and mode of contamination. Host genetic or environmental factors such as heterozygous MZ alpha1-antitrypsin deficiency or alcoholism, could also be potential risk factors for the development of cirrhosis. The aim of this study was to compare the prevalence of genotypes, alpha1-antitrypsin phenotype, past hepatitis B virus infection, and alcohol consumption in cirrhotic and noncirrhotic patients with chronic hepatitis C. We conducted a case-control study comparing 84 consecutive cirrhotic patients with chronic hepatitis C (cases) with 84 noncirrhotic patients with chronic hepatitis C (controls) selected from a cohort of 464 patients hospitalized during the same period. Controls were paired with cases according to age, sex, risk factors, and date of infection. HCV genotypes were determined using the InnoLiPA technique (Innogenetics, Zwijnaarde, Belgium) and classified according to the method of Simmonds. Patients were divided in three groups according to alcohol consumption: <30 g/d (light), 30 to 80 g/d (moderate), and >80 g/d (heavy). Cirrhotic and noncirrhotic patients were not significantly different in terms of genotype distribution (1a/1b/2a/3a/others/undetermined: 10/48/7/17/0/2 versus 11/43/10/10/5/5), alpha1-antitrypsin phenotype distribution (MM/MS/MZ: 84%/14%/2% vs. 87%/11%/2%, respectively), and prevalence of antibody to hepatitis B core antigen positivity (29% vs. 23%). Alcohol consumption was significantly different between cases and controls (L/M/H: 58%/27%/16% vs. 76%/15%/9%, respectively; P < .05). Two conclusions regarding patients with chronic hepatitis C virus infection can be drawn from this study: 1) viral genotype, especially 1b, past hepatitis B virus infection, and heterozygous MZ alpha1-antitrypsin deficiency are not risk factors for cirrhosis; and 2) alcohol consumption, even moderate, is a risk factor for cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9303512     DOI: 10.1002/hep.510260334

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  9 in total

1.  Comparison of hepatitis C viral loads in patients with or without coinfection with different genotypes.

Authors:  Alejandro Schijman; Rodney Colina; Sergey Mukomolov; Olga Kalinina; Laura García; Shobha Broor; Ajoy Varma Bhupatiraju; Peter Karayiannis; Baldip Khan; Cristina Mogdasy; Juan Cristina
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

2.  The epidemiology of hepatitis C in a UK health regional population of 5.12 million.

Authors:  A H Mohsen
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

Review 3.  Regulation of hepatocyte fate by interferon-γ.

Authors:  Christopher J Horras; Cheri L Lamb; Kristen A Mitchell
Journal:  Cytokine Growth Factor Rev       Date:  2011-02-18       Impact factor: 7.638

Review 4.  Alcoholic liver disease and hepatitis C: a frequently underestimated combination.

Authors:  Sebastian Mueller; Gunda Millonig; Helmut K Seitz
Journal:  World J Gastroenterol       Date:  2009-07-28       Impact factor: 5.742

5.  Clinical Profiles of Chronic Hepatitis C in a Major County Medical Center Outpatient Setting in United States.

Authors:  Ke-Qin Hu; Huiying Yang; Ying-Chao Lin; Karen L Lindsay; Allan G Redeker
Journal:  Int J Med Sci       Date:  2004-06-01       Impact factor: 3.738

6.  Red Blood Cell Distribution Width-to-Platelet Ratio and Other Laboratory Indices Associated with Severity of Histological Hepatic Fibrosis in Patients with Autoimmune Hepatitis: A Retrospective Study at a Single Center.

Authors:  Xu Li; Hongqin Xu; Pujun Gao
Journal:  Med Sci Monit       Date:  2020-11-12

7.  Alpha-1-antitrypsin phenotypes in adult liver disease patients.

Authors:  Aleksandra Topic; Tamara Alempijevic; Aleksandra Sokic Milutinovic; Nada Kovacevic
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

8.  Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment.

Authors:  Paola Dongiovanni; Quentin M Anstee; Luca Valenti
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

9.  Strong correlation by ultrasonography of hepatomegaly and the presence of co-infection in HIV/HCV cirrhotic patients.

Authors:  Denise Cerqueira Paranaguá Vezozzo; Maria Cassia Mendes-Correa; Marlone Cunha-Silva; Mónica Viviana Alvarado-Mora; João Ítalo Dias França; José Luiz Sebba; Antonio Carlos Nicodemo; Claudia P M S Oliveira; Flair José Carrilho
Journal:  Braz J Infect Dis       Date:  2013-02-27       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.